
Johnny Huang
Board Director & InvestorJohnny Huang, Ph.D. in Engineering Management from the University of Missouri-Rolla, is the founder and chairman of Brogent Technologies, a publicly listed company in Taiwan.His experience in engineering and business strategy strengthens T3’s global partnerships and investor relations.
Dr. Johnny Huang is a visionary leader with a strong background in engineering management and business strategy, combining technical expertise with entrepreneurial acumen. As the founder and chairman of Brogent Technologies, a publicly listed company in Taiwan, he has successfully led the development of cutting-edge engineering solutions while navigating complex global markets. His Ph.D. in Engineering Management from the University of Missouri-Rolla has equipped him with a deep understanding of technology commercialization, operational efficiency, and strategic growth planning. With a proven track record in building and scaling businesses, he plays a crucial role in strengthening T3 BioScience’s global partnerships and investor relations, leveraging his experience to drive international expansion and secure key financial and technological collaborations.
His ability to align engineering innovations with market demands makes him an invaluable asset in the biotechnology and technology sectors.
Dr. Johnny Huang’s research focuses on engineering management, technology commercialization, and strategic business growth, aiming to bridge innovation with global market opportunities.
- Link 1
- Link 2
- Link 3
- Link 4
- Link 5
- Link 6